 |
|
|
| |
C-SWIFT Retreatment (Part B): 12 Weeks of
Elbasvir/Grazoprevir with Sofosbuvir and Ribavirin Successfully Treated G1-Infected Subjects who Failed Short-Duration All-Oral Therapy
|
| |
| |
Reported by Jules Levin
AASLD 2015 Nov 13-17 San Francisco
Eric Lawitz1; Fred Poordad1; Julio A. Gutierrez1; Jennifer T. Wells1;
Carmen E. Landaverde1; Joseph R. Reiling2; Jerry J. Li2; Hsueh-Cheng Huang2;
Michael Robertson2; Janice Wahl2; Eliav Barr2; Barbara A. Haber2
1Texas Liver Institute, San Antonio, TX, USA; 2Merck & Co., Inc., Kenilworth, NJ, USA
|
| |
|
|
|
|
|
